Overall, these results show that Kv1.3 blockade can inhibit pro-inflammatory DAM gene expression and promote anti-inflammatory DAM gene expression while promoting phagocytic Aβ clearance, a protective function of DAM in AD. The gene discussed is KCNA3; the disease is Alzheimer disease.